Clinical Trial: Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial of Fourteen Day Treatment With Lansoprazole 15 mg or 30 mg Once a Day in Frequent Nighttime Same as current

Current Secondary Outcome: Proportion of 24 hour days with no heartburn during 14 days of treatment. Proportion of subjects with no heartburn during day 1 (the 24 hours following the first dose. The evaluation of lansoprazole safety. [ Time Frame: 14 days ]

Original Secondary Outcome: Same as current

Information By: Novartis

Dates:
Date Received: June 17, 2008
Date Started: January 2007
Date Completion:
Last Updated: January 13, 2010
Last Verified: January 2010